{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:49:42Z","timestamp":1761540582225},"reference-count":21,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1016\/j.thromres.2004.10.009","type":"journal-article","created":{"date-parts":[[2004,12,15]],"date-time":"2004-12-15T15:18:52Z","timestamp":1103123932000},"page":"475-481","source":"Crossref","is-referenced-by-count":30,"title":["Incidence of heparin-PF4 complex antibody formation and heparin-induced thrombocytopenia in acute coronary syndrome"],"prefix":"10.1016","volume":"115","author":[{"given":"Takefumi","family":"Matsuo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanobu","family":"Tomaru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuomi","family":"Kario","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Hirokawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2004.10.009_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0037-1614206","article-title":"Heparin-induced thrombocytopenia: towards consensus","volume":"79","author":"Warkentin","year":"1998","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2004.10.009_bib2","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/(SICI)1096-8652(199606)52:2<90::AID-AJH4>3.0.CO;2-0","article-title":"Generation of antibodies to heparin-PF4 complexes without thrombocytopenia in patients treated with unfractionated or low-molecular-weight heparin","volume":"52","author":"Amiral","year":"1996","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.thromres.2004.10.009_bib3","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1055\/s-0037-1615864","article-title":"Heparin-induced thrombocytopenia: a clinicopathologic syndrome","volume":"82","author":"Warkentin","year":"1999","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2004.10.009_bib4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0003-4975(02)04349-7","article-title":"Comparison of bovine and porcine heparin in heparin antibody formation after cardiac surgery","volume":"75","author":"Francis","year":"2003","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.thromres.2004.10.009_bib5","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1056\/NEJM200104263441704","article-title":"Temporal aspects of heparin-induced thrombocytopenia","volume":"344","author":"Warkentin","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2004.10.009_bib6","doi-asserted-by":"crossref","first-page":"210","DOI":"10.7326\/0003-4819-136-3-200202050-00009","article-title":"Delayed-onset heparin-induced thrombocytopenia","volume":"136","author":"Rice","year":"2002","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.thromres.2004.10.009_bib7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/00001721-199701000-00003","article-title":"Early onset of immunological heparin-induced thrombocytopenia in acute myocardial infarction","volume":"8","author":"Suzuki","year":"1997","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.thromres.2004.10.009_bib8","doi-asserted-by":"crossref","first-page":"s13","DOI":"10.1023\/A:1027372901367","article-title":"Mechanisms of venous and arterial thrombosis in heparin-induced thrombocytopenia","volume":"10","author":"Walenga","year":"2001","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.thromres.2004.10.009_bib9","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1046\/j.1538-7836.2003.00282.x","article-title":"Does negative heparin-platelet factor 4 enzyme-linked immunosorbent assay effectively exclude heparin-induced thrombocytopenia?","volume":"1","author":"Fohlen-Walter","year":"2003","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2004.10.009_bib10","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1538-7836.2004.00551.x","article-title":"Rapid generation of thrombin by atheroma and platelets","volume":"2","author":"Niemetz","year":"2004","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2004.10.009_bib11","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/(SICI)1096-8652(199606)52:2<90::AID-AJH4>3.0.CO;2-0","article-title":"Generation of antibodies to heparin-PF4 complexes without thrombocytopenia in patients treated with unfractionated or low-molecular-weight heparin","volume":"52","author":"Amiral","year":"1996","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.thromres.2004.10.009_bib12","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1046\/j.1365-2141.2002.03687.x","article-title":"Incidence and clinical relevance of heparin-induced antibodies in patients with deep vein thrombosis treated with unfractionated or low-molecular-weight heparin","volume":"118","author":"Lindhoff-Last","year":"2002","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2004.10.009_bib13","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1046\/j.1365-2141.1998.00750.x","article-title":"High incidence of anti-heparin\/platelet factor 4 antibodies after cardiopulmonary bypass","volume":"101","author":"Trossaert","year":"1998","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2004.10.009_bib14","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1161\/01.CIR.99.19.2530","article-title":"Antibodies to platelet factor 4-heparin after cardiopulmonary bypass in patients anticoagulated with unfractionated heparin or a low-molecular-weight heparin: clinical implications for heparin-induced thrombocytopenia","volume":"99","author":"Pouplard","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2004.10.009_bib15","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood.V96.5.1703","article-title":"Impact of the patient population on the risk of heparin-induced thrombocytopenia","volume":"96","author":"Warkentin","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2004.10.009_bib16","article-title":"Trends in incidence and diagnosis of heparin-induced thrombocytopenia at a tertiary medical center","volume":"1","author":"Francis","year":"2003","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2004.10.009_bib17","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1046\/j.1365-2141.1997.d01-2056.x","article-title":"Heparin-induced thrombocytopenia and thrombosis: a prospective analysis of the incidence in patients with heart and cerebrovascular diseases","volume":"96","author":"Kappers-Klunne","year":"1997","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2004.10.009_bib18","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0049-3848(99)00237-6","article-title":"Antithrombotic treatment (argatroban vs. heparin) in coronary angioplasty in angina pectoris: affects on inflammatory, hemostatic, and endothelium-derived parameters","volume":"98","author":"Suzuki","year":"2000","journal-title":"Thromb. Res."},{"issue":"Suppl. 1","key":"10.1016\/j.thromres.2004.10.009_bib19","first-page":"23","article-title":"Endothelial call hyperplasia contributes to thrombosis in heparin-induced thrombocytopenia","volume":"25","author":"Kwaan","year":"1999","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2004.10.009_bib20","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0002-9343(99)00124-2","article-title":"Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia","volume":"106","author":"Wallis","year":"1999","journal-title":"Am. J. Med."},{"key":"10.1016\/j.thromres.2004.10.009_bib21","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/ccd.10276","article-title":"Argatroban anticoagulation during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia","volume":"57","author":"Lewis","year":"2002","journal-title":"Catheter. Cardiovasc. Interv."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004938480400547X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004938480400547X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,4]],"date-time":"2020-04-04T19:00:43Z","timestamp":1586026843000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004938480400547X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S004938480400547X"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2004.10.009","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}